\
&
Contact us
\
&
Contact us
Published on | 3 years ago
ProgrammesNCP Flanders informed you of the adoption of the Horizion Europe 2023-2024 Work Programme and publication on the EU Funding & Tenders Portal.
NCP Flanders offers on its website a handy, up-to-date Call Topics Overview, a weekly updated Excel file which enables you to quickly find back relevant call topic information.
The domain specific pages of the NCP Flanders website have also been updated. For each of the Horizon Europe subprogrammes, the Work Programme and open/forthcoming calls are now also accessible via our pages:
- Pillar I - Marie Sklodowska-Curie Actions
- Pillar I - Research Infrastructures
- Pillar II - Cluster 1 Health
- Pillar II - Cluster 2 Culture and Society
- Pillar II - Cluster 3 - Security
- Pillar II - Cluster 4 - Digital, Industry, Space
- Pillar II - Cluster 5 - Climate, Energy, Mobility
- Pillar II - Cluster 6 - Agro-food, Evironment
- Pillar III - Eurpean Innovation Ecosystems
- Pillar III - European Innovation Council (WP 2023 available though not yet in EU Funding & Tenders Portal)
- Widening participation & Spreading Excellence
- Reforming & Enhancing the European R&I System
- EU Missions
NCP Flanders has also updated the information on the upcoming Horizon Europe Info Days organised by the Commission and on Brokerage events. You can find the latest information in our event calendar and an overview of all events here below:
- Research Infrastructures (Pillar I): Info day on 6 December - Rewatch
- Cluster 1: Info Day on 19 January 2023; Brokerage event on 20 January 2023 (incl. Cancer Mission)
- Cluster 2: Info day on 17 January 2023; Brokerage event on 18-19 January 2023
- Cluster 4: Info days on 12-14 December; Brokerage events on 8, 14 and 15-16 December
- Cluster 5: Info days on 15-16 December; Brokerage event on 15 December
- Cluster 6: Info days on 13-14 December; Brokerage event on 19 December
- European Innovation Council: Info day on 13 December
- Widening & European Research Area (ERA) actions: Info day on 12 December and Brokerage event (ERA) on 19 December
- EU Missions: Info Days on 17-18 January 2023 (TBC)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
